当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析 - 现金流量表

派林生物

(000403)

  

流通市值:89.84亿  总市值:90.76亿
流通股本:9.41亿   总股本:9.50亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,781,779,678.471,104,422,278.18474,645,161.972,126,498,241.35
  收到的税费返还9,168,835.248,823,835.24-5,367,630.65
  收到其他与经营活动有关的现金58,510,142.6421,389,432.495,452,119.6633,882,533.96
  经营活动现金流入小计1,849,458,656.351,134,635,545.91480,097,281.632,165,748,405.96
  购买商品、接受劳务支付的现金984,770,356.25674,105,472.67374,194,999.431,439,516,459.3
  支付给职工以及为职工支付的现金284,800,372.49205,111,123.6113,372,082.92354,237,291.72
  支付的各项税费186,927,056.44144,682,989.9786,816,287.42223,234,516.9
  支付其他与经营活动有关的现金277,023,544.95194,607,718.1177,565,467364,750,751.3
  经营活动现金流出小计1,733,521,330.131,218,507,304.35651,948,836.772,381,739,019.22
  经营活动产生的现金流量净额115,937,326.22-83,871,758.44-171,851,555.14-215,990,613.26
二、投资活动产生的现金流量:
  收回投资收到的现金540,026,867.96450,026,867.96300,000,0001,480,000,000
  取得投资收益收到的现金8,277,403.797,918,743.672,723,573.6117,593,226.86
  处置固定资产、无形资产和其他长期资产收回的现金净额60,214.2731,686.31,911.5493,018.55
  收到的其他与投资活动有关的现金35,227,397.2623,852,054.7913,315,068.4953,999,999.98
  投资活动现金流入小计583,591,883.28481,829,352.72316,040,553.61,552,086,245.39
  购建固定资产、无形资产和其他长期资产支付的现金143,228,934.5569,982,470.3733,776,304.86333,403,421.77
  投资支付的现金735,000,000460,000,000310,000,0001,450,000,000
  支付其他与投资活动有关的现金150,000,000150,000,000100,000,000-
  投资活动现金流出小计1,028,228,934.55679,982,470.37443,776,304.861,783,403,421.77
  投资活动产生的现金流量净额-444,637,051.27-198,153,117.65-127,735,751.26-231,317,176.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金---100,000
  其中:子公司吸收少数股东投资收到的现金---100,000
  取得借款收到的现金912,201,588.59658,102,000103,500,000771,207,747.13
  筹资活动现金流入小计912,201,588.59658,102,000103,500,000771,307,747.13
  偿还债务支付的现金733,504,551.38268,228,790.87133,133,164.62595,309,148.65
  分配股利、利润或偿付利息支付的现金15,935,000.6610,772,746.454,858,839.98273,799,760.63
  支付其他与筹资活动有关的现金141,792,372.96118,500,949.23517,811.015,704,350.38
  筹资活动现金流出小计891,231,925397,502,486.55138,509,815.61874,813,259.66
  筹资活动产生的现金流量净额20,969,663.59260,599,513.45-35,009,815.61-103,505,512.53
四、汇率变动对现金及现金等价物的影响-83,586.16-62,263.45-31,771.3849,364.89
五、现金及现金等价物净增加额-307,813,647.62-21,487,626.09-334,628,893.39-550,763,937.28
  加:期初现金及现金等价物余额769,596,617.33769,596,617.33769,596,617.331,320,360,554.61
  期末现金及现金等价物余额461,782,969.71748,108,991.24434,967,723.94769,596,617.33
补充资料:
  净利润-84,973,590.59-419,535,951.9
  资产减值准备-365,386.04-100,052,963.37
  固定资产和投资性房地产折旧-66,071,438.48-116,414,975.28
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-66,071,438.48-116,386,495.44
    投资性房地产折旧---28,479.84
  无形资产摊销-11,211,647.93-20,591,534.24
  长期待摊费用摊销-10,291,730.72-9,271,024.41
  处置固定资产、无形资产和其他长期资产的损失-135,615.12--756,002.27
  固定资产报废损失-372,752.16-754,255.1
  公允价值变动损失-180,180.4--4,296,114.07
  财务费用--11,041,273.76--32,814,439.01
  投资损失--3,538,606.1--8,953,532.37
  递延所得税--783,989.13-2,593,122.97
  其中:递延所得税资产减少-1,596,345.38-2,843,705.76
    递延所得税负债增加--2,380,334.51--250,582.79
  存货的减少--337,560,871.97--332,406,933.51
  经营性应收项目的减少-131,101,047.96--472,671,425.47
  经营性应付项目的增加--37,014,482.76--47,788,798.62
  现金的期末余额-748,108,991.24-769,596,617.33
  减:现金的期初余额-769,596,617.33-1,320,360,554.61
  现金及现金等价物的净增加额--21,487,626.09--550,763,937.28
公告日期2026-10-222026-08-242026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑